Nao Sakai-Yoshida

St. Mary's Hospital, 422 Tsubukuhonmachi
Kurume, 8308543, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Immature platelet fraction and bone marrow findings in hematology.

Immature platelet fraction and bone marrow findings in hematology.

Journal: Scientific reports
Published: April 22, 2025

Efficacy of Anti-CD38 Monoclonal Antibodies for Relapsed or Refractory Multiple Myeloma in Stem Cell Transplant-Ineligible Patients Aged over 65 Years: A Propensity Score-Matched Study.

Efficacy of Anti-CD38 Monoclonal Antibodies for Relapsed or Refractory Multiple Myeloma in Stem Cell Transplant-Ineligible Patients Aged over 65 Years: A Propensity Score-Matched Study.

Journal: Hematology reports
Published: August 30, 2024

Enhanced ALOX12 Gene Expression Predicts Therapeutic Susceptibility to 5-Azacytidine in Patients with Myelodysplastic Syndromes.

Enhanced ALOX12 Gene Expression Predicts Therapeutic Susceptibility to 5-Azacytidine in Patients with Myelodysplastic Syndromes.

Journal: International journal of molecular sciences
Published: March 28, 2024

Reprogramming of pyrimidine nucleotide metabolism supports vigorous cell proliferation of normal and malignant T cells.

Reprogramming of pyrimidine nucleotide metabolism supports vigorous cell proliferation of normal and malignant T cells.

Journal: Blood advances
Published: July 05, 2023

A Combination of Alectinib and DNA-Demethylating Agents Synergistically Inhibits Anaplastic-Lymphoma-Kinase-Positive Anaplastic Large-Cell Lymphoma Cell Proliferation.

A Combination of Alectinib and DNA-Demethylating Agents Synergistically Inhibits Anaplastic-Lymphoma-Kinase-Positive Anaplastic Large-Cell Lymphoma Cell Proliferation.

Journal: Cancers
Published: May 01, 2023

Combination of a New Oral Demethylating Agent, OR2100, and Venetoclax for Treatment of Acute Myeloid Leukemia.

Combination of a New Oral Demethylating Agent, OR2100, and Venetoclax for Treatment of Acute Myeloid Leukemia.

Journal: Cancer research communications
Published: July 01, 2022

Dual targeting of aberrant DNA and histone methylation synergistically suppresses tumor cell growth in ATL.

Dual targeting of aberrant DNA and histone methylation synergistically suppresses tumor cell growth in ATL.

Journal: Blood advances
Published: June 17, 2022

Adult T-cell leukemia-lymphoma acquires resistance to DNA demethylating agents through dysregulation of enzymes involved in pyrimidine metabolism.

Adult T-cell leukemia-lymphoma acquires resistance to DNA demethylating agents through dysregulation of enzymes involved in pyrimidine metabolism.

Journal: International journal of cancer
Published: August 12, 2021

Coexistence of gastric and pulmonary MALT lymphoma and a clonally related, disseminated large B cell lymphoma with conspicuous angiotropism.

Coexistence of gastric and pulmonary MALT lymphoma and a clonally related, disseminated large B cell lymphoma with conspicuous angiotropism.

Journal: Annals of hematology
Published: June 22, 2021

Acute myeloid leukaemia presenting with ecthyma gangrenosum as the first manifestation: A case report.

Acute myeloid leukaemia presenting with ecthyma gangrenosum as the first manifestation: A case report.

Journal: Medicine
Published: January 28, 2021

Silylation of Deoxynucleotide Analog Yields an Orally Available Drug with Antileukemia Effects.

Silylation of Deoxynucleotide Analog Yields an Orally Available Drug with Antileukemia Effects.

Journal: Molecular cancer therapeutics
Published: December 28, 2020
Showing 1-11 of 11

Last Updated: 09/26/2026